Oosterholt S - Search Results

1

Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome.

Glaze DG, Neul JL, Kaufmann WE, Berry-Kravis E, Condon S, Stoms G, Oosterholt S, Della Pasqua O, Glass L, Jones NE, Percy AK; Rett 002 Study Group. Glaze DG, et al. Among authors: oosterholt s. Neurology. 2019 Apr 16;92(16):e1912-e1925. doi: 10.1212/WNL.0000000000007316. Epub 2019 Mar 27. Neurology. 2019. PMID: 30918097 Free PMC article. Clinical Trial.

2

Biomarker exposure-response relationships as the basis for rational dose selection: Lessons from a simulation exercise using a selective COX-2 inhibitor.

Taneja A, Oosterholt SP, Danhof M, Della Pasqua O. Taneja A, et al. J Clin Pharmacol. 2016 May;56(5):609-21. doi: 10.1002/jcph.629. Epub 2015 Dec 27. J Clin Pharmacol. 2016. PMID: 26331692 Clinical Trial.

3

Population pharmacokinetics of NNZ-2566 in healthy subjects.

Oosterholt SP, Horrigan J, Jones N, Glass L, Della Pasqua O. Oosterholt SP, et al. Eur J Pharm Sci. 2017 Nov 15;109S:S98-S107. doi: 10.1016/j.ejps.2017.05.032. Epub 2017 May 15. Eur J Pharm Sci. 2017. PMID: 28522374 Clinical Trial.

4

Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura.

Taylor A, Vendramin C, Oosterholt S, Della Pasqua O, Scully M. Taylor A, et al. Among authors: oosterholt s. J Thromb Haemost. 2019 Jan;17(1):88-98. doi: 10.1111/jth.14345. Epub 2018 Dec 31. J Thromb Haemost. 2019. PMID: 30475428 Free article.

5

Use of prior knowledge and extrapolation in paediatric drug development: A case study with deferasirox.

Borella E, Oosterholt S, Magni P, Della Pasqua O. Borella E, et al. Among authors: oosterholt s. Eur J Pharm Sci. 2019 Aug 1;136:104931. doi: 10.1016/j.ejps.2019.05.009. Epub 2019 May 18. Eur J Pharm Sci. 2019. PMID: 31108206

6

A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1).

Horrigan J, Gomes TB, Snape M, Nikolenko N, McMorn A, Evans S, Yaroshinsky A, Della Pasqua O, Oosterholt S, Lochmüller H. Horrigan J, et al. Among authors: oosterholt s. Pediatr Neurol. 2020 Nov;112:84-93. doi: 10.1016/j.pediatrneurol.2020.08.001. Epub 2020 Aug 5. Pediatr Neurol. 2020. PMID: 32942085 Free article. Clinical Trial.

7

Population pharmacokinetics of raxibacumab in healthy adult subjects.

Oosterholt SP, Della Pasqua O. Oosterholt SP, et al. Br J Clin Pharmacol. 2021 Dec;87(12):4718-4725. doi: 10.1111/bcp.14894. Epub 2021 Jul 14. Br J Clin Pharmacol. 2021. PMID: 33973655 Free article. Clinical Trial.

8

Extrapolation and dosing recommendations for raxibacumab in children from birth to age <18 years.

Oosterholt SP, Della Pasqua O. Oosterholt SP, et al. Br J Clin Pharmacol. 2021 Dec;87(12):4709-4717. doi: 10.1111/bcp.14893. Epub 2021 Jul 13. Br J Clin Pharmacol. 2021. PMID: 33974281 Free article.

9

Characterisation of individual ferritin response in patients receiving chelation therapy.

Borella E, Oosterholt S, Magni P, Della Pasqua O. Borella E, et al. Among authors: oosterholt s. Br J Clin Pharmacol. 2022 Aug;88(8):3683-3694. doi: 10.1111/bcp.15290. Epub 2022 Mar 26. Br J Clin Pharmacol. 2022. PMID: 35199367 Free PMC article.

10

Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate-Severe Symptoms.

Singh D, Oosterholt S, Pavord I, Garcia G, Abhijith Pg, Della Pasqua O. Singh D, et al. Among authors: oosterholt s. Adv Ther. 2023 Oct;40(10):4606-4625. doi: 10.1007/s12325-023-02590-2. Epub 2023 Aug 17. Adv Ther. 2023. PMID: 37589831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page